You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 11, 2024

Litigation Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)

Docket ⤷  Try a Trial Date Filed 2019-09-15
Court United States Bankruptcy Court, S.D. New York Date Terminated
Cause Assigned To Sean H. Lane
Jury Demand Referred To
Parties BAYARD, P.A.; KROLL RESTRUCTURING ADMINISTRATION LLC; KROLL RESTRUCTURING ADMINISTRATION LLC CLAIMS AGENT; PURDUE PHARMA L.P.; UNITED STATES TRUSTEE
Patents 10,004,819; 10,006,091; 10,011,659; 10,011,857; 10,017,712; 10,058,630; 10,114,022; 10,125,364; 10,300,010; 10,407,434; 6,004,968; 6,398,671; 7,005,420; 7,048,928; 7,423,050; 7,658,945; 7,777,050; 7,897,050; 7,982,078; 8,003,762; 8,007,830; 8,008,003; 8,008,006; 8,017,074; 8,080,575; 8,134,000; 8,269,040; 8,313,778; 8,337,888; 8,653,033; 8,722,684; 9,023,001; 9,023,391; 9,060,976; 9,073,933; 9,090,815; 9,090,945; 9,193,757; 9,522,919; 9,555,000; 9,700,050; 9,730,934
Attorneys Chane Buck; Darren S. Klein; Dennis Windscheffel; George W. Shuster, Jr.; Jeffrey R. Gleit; Nathan Yeary; Van C. Durrer, II
Firms Akin Gump Strauss Hauer & Feld, LLP; Akin Gump Strauss Hauer and Feld; Dennis Windscheffel; Office of the United States Trustee; Skadden, Arps, Slate, Meagher & Flom LLP; Sullivan and Worcester LLP; Wilmer, Cutler, Pickering, Hale & Dorr, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P.

Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-05-30 1195 Monthly Fee Statement .7). $5,420.00…Hourly Rates for Patent Services [Docket No. 965] (the “Notice of Increased Patent Fees”). …10% for patent agents. 6 As described in the Notice of Increased Patent Fees,…Hourly Rates for Patent Services [Docket No. 965] (the “Notice of Increased Patent Fees”). 19-23649… U.S. Patent and Trademark Office Electronic Patent Assignments External link to document
2020-06-03 1220 Monthly Fee Statement $1,080 4.6 $4,968.00 2017; admitted…regarding patent assignments. Chen, Bonnie 04/03/20 2.5 Revise patent assignments…regarding patent assignments (0.5); revise patent assignments… patent assignments (0.3); review patents for documentary due … deck slides related to patent assignments (0.2); revise patent External link to document
2020-07-14 1382 Monthly Fee Statement Litigation 2017 $650.00 14.70 $9,555.00 Anthony Hilbert Corporate 2019… 14.70 at $650.00 = $9,555.00 R BAYEFSKY 12.90 … to patent licenses; research re statements in 4.40 patents (2.6…revise assessment of patents (1.2). 05/20/20 DCV 0032 Analyze patent license agreements and….30 05/01/20 DCV 0032 Review Purdue patents and file histories (1.6); update analysis re same External link to document
2020-07-15 1407 Application for Interim Professional Compensation 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …Litigation 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …in connection with analyzing the Debtors’ patents and patent applications, intellectual property license…related to patent history, prosecution, and expiration; product exclusivity and expiration of patent coverage… ongoing, former and potential patent litigation (in particular patent infringement litigation), and External link to document
2020-07-17 1441 Application for Interim Professional Compensation 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …Litigation 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …in connection with analyzing the Debtors’ patents and patent applications, intellectual property license…related to patent history, prosecution, and expiration; product exclusivity and expiration of patent coverage… ongoing, former and potential patent litigation (in particular patent infringement litigation), and External link to document
2020-07-20 1463 Response to Motion ,412, as U.S. Patent Nos. 8,337,888 (the “’888 patent”); 9,060,976 (the “’976 patent”); and 9,034,376…certain of the Debtors’ patents, including U.S. Patent No. 9,693,961 (“the ’961 Patent”). Shortly after the… Patent 9,693,961 B2 A. Related Proceedings Patent Owner asserted the ’961 patent against…Response, Patent Owner contends that, “transitional” continuation patents such as the ’961 patent are not…before the Patent Trial and Appeal Board (the “PTAB”), seeking a determination that the ’961 patent was invalid External link to document
2020-08-19 1592 Objection to Motion other patents in suit – U.S. Patent Nos. 9,073,933 (“’933 Patent”) and 9,522,919 (“’919 Patent”). These…of one of the Debtors’ patents, U.S. Patent No. 9,693,961 B2 (the “’961 Patent”). Collegium’s Response…’961 Patent — the subject of the PTAB Action — is just one of the patents in suit in the Patent Litigation…Action”) before the United States Patent and Trademark Office’s Patent Trial and Appeal Board (the “PTAB…These patents are not related to the ’961 Patent — they have different specifications, different records External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.